Despite inevitable hiccups, Conservative Equities’ track record shows our approach adds value. Since inception, our flagship strategies have been able to beat both the market and generic low-risk products.
For over 13 years now, the Robeco Conservative Equities approach has proven able to deliver added value in both developed and emerging markets. Our flagship strategies in both categories have outperformed their two reference indices, the market index and the main minimum volatility index, gross of fees, as shown in Figure 1.
But it hasn’t all been smooth sailing. There have also been occasional bumps along the way, with periods of lagging performance. In other words, we won’t beat all the indices all the time.
Such hiccups are inevitable for an active low-risk strategy that is benchmark-agnostic, unconstrained by tracking error limits, and characterized by a typical active share of 80% versus the market index and around 70% versus the minimum volatility index, as provided by MSCI. Moreover, weaker periods have always been followed by strong recovery, supporting the long-term track record.
Conservative Equities is an active low-risk strategy, aiming for long-term stable returns and a high income. Its diversified and actively positioned portfolio is created through a factor-based, bottom-up stock selection process and a straightforward portfolio construction process. The objective is to maximize the absolute return-risk ratio over a full performance cycle.
Currently, our Global Developed Conservative Equities strategy seems to be going through one of these rougher patches, in particular when compared to the MSCI World Minimum Volatility Index. Comparatively, the strategy’s performance relative to the MSCI World Index has been more consistent with expectations.
The main reason for the recent higher return for the minimum volatility index has been its bias towards low-risk stocks with a higher valuation, as expensive stocks outperformed cheap stocks. Conservative Equities has had, and still has, a valuation gap of around 20% versus the index, as it selects low-risk stocks with an attractive valuation, high pay-out yield and positive momentum.
Performance of Robeco Global Developed Conservative Equities strategy versus the MSCI World Minimum Volatility Index was especially weak in 2018. As a result, short-term performance of the strategy, up to five years, looks less strong relative to this specific index, while the long-term track record remains intact.
The situation is quite different in emerging markets, where the value factor has been a positive contributor to relative performance for our Emerging Conservative strategy over the last few years. In these markets, the strategy’s preference for low-risk, high-dividend emerging markets stocks has worked well, both versus the MSCI EM Index and MSCI EM Minimum Volatility Index.
Despite the recent value drag in developed markets, both strategies performed in line with expectations
Overall, however, despite the recent value drag in developed markets, both strategies performed in line with expectations. They lagged in strong bull markets, like in 2017 and during the periods of rising markets seen in 2018 and 2019. But they also delivered strong risk reduction in falling markets, like in February/March 2018, the last quarter of 2018, and in May and August 2019.
Moreover, we see the current valuation gap between Conservative Equities and the MSCI Minimum Volatility indices as an opportunity for future outperformance in both developed and emerging markets. This is especially the case given the lower expected equity returns that Robeco projects for the next five years.1
Over the last few years, most developed markets investors have focused on growth stocks that featured high earnings growth, regardless of valuations. This is not unusual behavior in a bullish, late-cycle phase of the market. But, as the market cycle matures, stocks with a high valuation and rapid earnings growth should lose some shine.
Dividend, capital protection, and reasonable valuation levels may in the meantime become more relevant again for investors, as they usually do in more difficult times. In such a scenario, we expect our focus on low-risk stocks with a high dividend yield and attractive valuation levels can show its added value once more, in both developed and emerging markets.
1See our latest ‘Expected Returns 2020-2024’ report for more details.
The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients.
The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA).
Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile.
Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports.